Fampridine (Fampyra) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Sep 4, 2026

Some Fampridine products are in shortage in Canada (1 of 3 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Oct 2, 2026.

A medication used to improve walking in adults with multiple sclerosis.

Products affected

1 / 3

In shortage since

Sep 1, 2026

Est. full return

Oct 2, 2026

Reports on file

Talk to a pharmacist

Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.

Book a pharmacist appointment

Need your prescription switched?

If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.

See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage

TARO-FAMPRIDINE

10MG · TABLET (EXTENDED-RELEASE) · TARO PHARMACEUTICALS INC

DIN 02482398 · since Sep 1, 2026, est. end Oct 2, 2026 · Disruption of the manufacture of the drug.

Resolved

TARO-FAMPRIDINE

10MG · TABLET (EXTENDED-RELEASE) · TARO PHARMACEUTICALS INC

DIN 02482398 · ended Jan 12, 2025 · Disruption of the manufacture of the drug.

Resolved

PMS-FAMPRIDINE

10MG · TABLET (EXTENDED-RELEASE) · PHARMASCIENCE INC

DIN 02496216 · ended Dec 8, 2022 · Disruption of the manufacture of the drug.

Resolved

FAMPYRA

10MG · TABLET (EXTENDED-RELEASE) · BIOGEN CANADA INC

DIN 02379910 · ended Nov 17, 2022 · Disruption of the manufacture of the drug.

What's happening

Fampridine is currently affected by an active shortage report filed with Health Canada by TARO PHARMACEUTICALS INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Fampridine is classified under “OTHER NERVOUS SYSTEM DRUGS” (ATC N07XX).

Recent changes

Sep 4, 2026 New report filed

Common questions

What is Fampridine used for?

A medication used to improve walking in adults with multiple sclerosis.

When will Fampridine be back in stock in Canada?

The latest manufacturer estimate is Oct 2, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Fampridine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (other nervous system drugs)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Tetrabenazine (Nitoman) No current shortage Riluzole (Rilutek) Partial shortage 1 of 3 reported products affected · est. return Feb 9, 2027

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.